Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapy

Arthritis Research and Therapy

Volumn 11, Issue 6, 2009, Pages

  Leboime, Ariane ^a   Berthelot, Jean Marie ^b   Allanore, Yannick ^c   Khalil Kallouche, Lama ^a   Herman, Philippe ^d   Orcel, Philippe ^a   Lioté, Frédéric ^a  

^a CENTRE VIGGO PETERSEN   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c Hôpital Cochin Paris Descartes University ^*  (France)

^d HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; INFLIXIMAB; ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; ASPERGILLOMA; ASPERGILLOSIS; CENTRAL NERVOUS SYSTEM ASPERGILLOSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DESCRIPTIVE RESEARCH; HUMAN; LUNG ASPERGILLOSIS; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SINUSITIS; SYSTEMATIC REVIEW; DRUG ANTAGONISM; MIDDLE AGED; PARANASAL SINUS DISEASE;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ASPERGILLOSIS; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; PARANASAL SINUS DISEASES; RECEPTORS, TUMOR NECROSIS FACTOR; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77952466510     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2849     Document Type: Article

References (50)

1. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002, 46:2287-2293. 10.1002/art.10524, 12355475.
2. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007, 7:429-442. 17525752, 10.1038/nri2094.
3. Franklin J, Lunt M, Bunn D, Symmons D, Silman A. Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis. Ann Rheum Dis 2007, 66:308-312. 10.1136/ard.2006.057265, 16984941.
4. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006, 295:2275-2285. 10.1001/jama.295.19.2275, 16705109.
5. Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2006, 54:2368-2376. 10.1002/art.21978, 16868999.
6. Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 2004, 38:1261-1265. 10.1086/383317, 15127338.
7. Gardam MA, Keystone EC, Menzies R, Manners S, Skamene E, Long R, Vinh DC. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 2003, 3:148-155. 10.1016/S1473-3099(03)00545-0, 12614731.
8. Furst DE, Cush J, Kaufmann S, Siegel J, Kurth R. Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agents. Ann Rheum Dis 2002, 61(Suppl 2):ii62-ii63. 1766699, 12379625.
9. Mariette X, Salmon D. French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers. Ann Rheum Dis 2003, 62:791. Letter, 10.1136/ard.62.8.791, 1754631, 12860745.
10. Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP. Fungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc 2008, 83:181-194. 10.4065/83.2.181, 18241628.
11. Michaud K, Wolfe F. The association of rheumatoid arthritis and its treatment with sinus disease. J Rheum 2006, 33:2412-2415.
12. Ferreiro JA, Carlson BA, Cody DT. Paranasal sinus fungus balls. Head Neck 1997, 19:481-486. 10.1002/(SICI)1097-0347(199709)19:6<481::AID-HED4>3.0.CO;2-V, 9278755.
13. Arnett FC. Revised criteria for the classification of rheumatoid arthritis. Bull Rheum Dis 1989, 38:1-6.
14. Drakos PE, Nagler A, Or R, Naparstek E, Kapelushnik J, Engelhard D, Rahav G, Ne'emean D, Slavin S. Invasive fungal sinusitis in patients undergoing bone marrow transplantation. Bone Marrow Transplant 1993, 12:203-208.
15. Gungor A, Adusumilli V, Corey JP. Fungal sinusitis: progression of disease in immunosuppression - a case report. Ear Nose Throat J 1998, 77:207-210.
16. Milroy CM, Blanshard JD, Lucas S, Michaels L. Aspergillosis of the nose and paranasal sinuses. J Clin Pathol 1989, 42:123-127. 10.1136/jcp.42.2.123, 1141812, 2921352.
17. Elliott JA, Milne LJ, Cumming D. Chronic necrotising pulmonary aspergillosis treated with itraconazole. Thorax 1989, 44:820-821. 10.1136/thx.44.10.820, 1020850, 2556808.
18. Swoboda H, Ullrich R. Aspergilloma in the frontal sinus expanding into the orbit. J Clin Pathol 1992, 45:629-630. 10.1136/jcp.45.7.629, 495196, 1517468.
19. Slusher JR, Maldonado ME, Mousavi F, Lozada CJ. Central nervous system Aspergillus fumigatus presenting as cranial nerve palsy in a patient with ankylosing spondylitis on anti-TNF therapy. Rheumatology 2008, 47:739-740. 10.1093/rheumatology/ken088, 18381385.
20. Warris A, Bjorneklett A, Gaustad P. Invasive pulmonary aspergillosis associated with infliximab therapy. N Engl J Med 2001, 344:1099-1100. 10.1056/NEJM200104053441415, 11291675.
21. Erbek SS, Serefhanoglu K, Erbek S, Demirbilek M, Can F, Tarhan E, Turan H, Cakmak O. Clinical subgroups and antifungal susceptibilities in fungal culture-positive patients with chronic rhinosinusitis. Eur Arch Otorhinolaryngol 2008, 265:775-780. 10.1007/s00405-007-0542-3, 18043932.
22. Grosjean P, Weber R. Fungus balls of the paranasal sinuses: a review. Eur Arch Otorhinolaryngol 2007, 264:461-470. 10.1007/s00405-007-0281-5, 17361410.
23. Lowe J, Bradley J. Cerebral and orbital Aspergillus infection due to invasive aspergillosis of ethmoid sinus. J Clin Pathol 1986, 39:774-778. 10.1136/jcp.39.7.774, 500047, 3734114.
24. McCann S, Byrne JL, Rovira M, Shaw P, Ribaud P, Sica S, Volin L, Olavarria E, Mackinnon S, Trabasso P, VanLint MT, Ljungman P, Ward K, Browne P, Gratwohl A, Widmer AF, Cordonnier C, . Infectious Diseases Working Party of the EBMT Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes. Bone Marrow Transplant 2004, 33:519-529. 10.1038/sj.bmt.1704380, 14743201, Infectious Diseases Working Party of the EBMT.
25. Chang CC, Cheng AC, Devitt B, Hughes AJ, Campbell P, Styles K, Low J, Athan E. Successful control of an outbreak of invasive aspergillosis in a regional haematology unit during hospital construction works. J Hosp Infect 2008, 69:33-38. 10.1016/j.jhin.2008.02.010, 18394753.
26. Barry B, Topeza M, Gehanno P. Aspergillosis of the paranasal sinus and environmental factors. Ann Otolaryngol Chir Cervicofac 2002, 119:170-173.
27. Klossek JM, Serrano E, Peloquin L, Percodani J, Fontanel JP, Pessey JJ. Functional endoscopic sinus surgery and 109 mycetomas of paranasal sinuses. Laryngoscope 1997, 107:112-117. 10.1097/00005537-199701000-00021, 9001274.
28. Dahniya MH, Makkar R, Grexa E, Cherian J, al-Marzouk N, Mattar M, Saghir E, Fathi al-Samman T. Appearances of paranasal fungal sinusitis on computed tomography. Br J Radiol 1998, 71:340-344.
29. Mensi M, Salgarello S, Pinsi G, Piccioni M. Mycetoma of the maxillary sinus: endodontic and microbiological correlations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004, 98:119-123. 10.1016/j.tripleo.2003.12.035, 15243482.
30. Rowe-Jones JM, Moore-Gillon V. Destructive noninvasive paranasal sinus aspergillosis: component of a spectrum of disease. J Otolaryngol 1994, 23:92-96.
31. Macfarlane JD, Franken CK, van Leeuwen AW. Progressive cavitating pulmonary changes in rheumatoid arthritis: a case report. Ann Rheum Dis 1984, 43:98-101. 10.1136/ard.43.1.98, 1001232, 6696527.
32. O'Reilly S, Hartley P, Jeffers M, Casey E, Clancy L. Invasive pulmonary aspergillosis associated with low dose methotrexate therapy for rheumatoid arthritis: a case report of treatment with itraconazole. Tuber Lung Dis 1994, 75:153-155. 10.1016/0962-8479(94)90046-9, 8032050.
33. Buttgereit F, Kunzel K, Tietz HJ, Sajkiewicz K, Gellert K, Hiepe F, Burmester GR. Persistent pulmonary lesion in a patient with rheumatoid arthritis. Ann Rheum Dis 1994, 53:798-800. 10.1136/ard.53.12.798, 1005473, 7864686.
34. Nakajima J, Takamoto S, Tanaka M, Takeuchi E, Murakawa T. Thoracoscopic resection of the pulmonary aspergilloma: report of two cases. Chest 2000, 118:1490-1492. 10.1378/chest.118.5.1490, 11083707.
35. De Rosa FG, Shaz D, Campagna AC, Dellaripa PE, Khettry U, Craven DE. Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: a possible healthcare-associated case?. Infect Control Hosp Epidemiol 2003, 24:477-482. 10.1086/502250, 12887234.
36. Cavazza A, Paci M, Turrini E, Dallari R, Rossi G. Fungus colonisation of pulmonary rheumatoid nodule. J Clin Pathol 2003, 56:636-637. 10.1136/jcp.56.8.636, 1770030, 12890823.
37. Klooster JM, Bosman RJ, Oudemans-van Straaten HM, Spoel JI, Wester JP, Zandstra DF. Disseminated tuberculosis, pulmonary aspergillosis and cutaneous herpes simplex infection in a patient with infliximab and methotrexate. Intensive Care Med 2003, 29:2327-2329. 10.1007/s00134-003-1867-z, 14600805.
38. Lassoued S, Sire S, Farny M, Billey T, Lassoued K. Pulmonary aspergillosis in a patient with rheumatoid arthritis treated by etanercept. Clin Exp Rheumatol 2004, 22:267-268.
39. Cornillet A, Camus C, Nimubona S, Gandemer V, Tattevin P, Belleguic C, Chevrier S, Meunier C, Lebert C, Aupee M, Caulet-Maugendre S, Faucheux M, Lelong B, Leray E, Guiguen C, Gangneux JP. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis 2006, 43:577-584. 10.1086/505870, 16886149.
40. Winne L, Praet M, Brusselle G, Veys E, Mielants H. Bilateral spontaneous pneumothorax in a patient with pulmonary rheumatoid nodules, secondary infected by Aspergillus. Clin Rheumatol 2007, 26:1180-1182. 10.1007/s10067-006-0319-x, 16670823.
41. Jung N, Owczarczyk K, Hellmann M, Lehmann C, Fatkenheuer G, Hallek M, Rubbert A. Efficacy and safety of rituximab in a patient with active rheumatoid arthritis and chronic disseminated pulmonary aspergillosis and history of tuberculosis. Rheumatology 2008, 47:932-933. 10.1093/rheumatology/ken143, 18417524.
42. Kroot EJ, Demeyere T, Linden AN, Visser C, Traksel RA. Intracranial aspergilloma in a patient with rheumatoid arthritis. Scand J Rheum 2008, 37:233-234. 10.1080/03009740701867356, 18465461.
43. Krohn J, Halvorsen JH. Aspergilloma of the lung in ankylosing spondylitis. Scand J Respir Dis Suppl 1968, 63:131-132. 5294134.
44. Scobie BA. Disturbed oesophageal manometric responses in patients with ankylosing spondylitis and pulmonary aspergilloma. Australas Ann Med 1970, 19:131-134.
45. Stiksa G, Eklundh G, Riebe I, Simonsson BG. Bilateral pulmonary aspergilloma in ankylosing spondylitis treated with transthoracic intracavitary instillations of antifungal agents. Scand J Respir Dis 1976, 57:163-170.
46. Rosenow E, Strimlan CV, Muhm JR, Ferguson RH. Pleuropulmonary manifestations of ankylosing spondylitis. Mayo Clin Proc 1977, 52:641-649.
47. Rao RS, Curzon PG, Muers MF, Watson DA. Cavernoscopic evacuation of aspergilloma: an alternative method of palliation for haemoptysis in high risk patients. Thorax 1984, 39:394-396. 10.1136/thx.39.5.394, 459811, 6204396.
48. Franquet T, Muller NL, Flint JD. A patient with ankylosing spondylitis and recurrent haemoptysis. Eur Respir J 2004, 23:488-491. 10.1183/09031936.04.00042804, 15065843.
49. Pamuk ON, Harmandar O, Tosun B, Yoruk Y, Cakir N. A patient with ankylosing spondylitis who presented with chronic necrotising aspergillosis: report on one case and review of the literature. Clin Rheumatol 2005, 24:415-419. 10.1007/s10067-004-1047-8, 15616760.
50. Elter T, Sieniawski M, Gossmann A, Wickenhauser C, Schroder U, Seifert H, Kuchta J, Burhenne J, Riedel KD, Fatkenheuer G, Cornely OA. Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman. Int J Antimicrob Agents 2006, 28:262-265. 10.1016/j.ijantimicag.2006.04.006, 16908120.